Goldman Sachs’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-28,178
| Closed | -$138K | – | 5266 |
|
2025
Q1 | $138K | Sell |
28,178
-24,094
| -46% | -$118K | ﹤0.01% | 4761 |
|
2024
Q4 | $351K | Buy |
52,272
+22,495
| +76% | +$151K | ﹤0.01% | 4461 |
|
2024
Q3 | $230K | Sell |
29,777
-72,141
| -71% | -$558K | ﹤0.01% | 4445 |
|
2024
Q2 | $612K | Buy |
101,918
+61,447
| +152% | +$369K | ﹤0.01% | 3850 |
|
2024
Q1 | $365K | Sell |
40,471
-3,801
| -9% | -$34.3K | ﹤0.01% | 4115 |
|
2023
Q4 | $419K | Sell |
44,272
-94,229
| -68% | -$893K | ﹤0.01% | 4045 |
|
2023
Q3 | $1.65M | Buy |
138,501
+4,004
| +3% | +$47.6K | ﹤0.01% | 3212 |
|
2023
Q2 | $3.3M | Buy |
134,497
+26,287
| +24% | +$644K | ﹤0.01% | 2863 |
|
2023
Q1 | $3.39M | Buy |
108,210
+62,884
| +139% | +$1.97M | ﹤0.01% | 2832 |
|
2022
Q4 | $3.19M | Sell |
45,326
-50,033
| -52% | -$3.52M | ﹤0.01% | 2958 |
|
2022
Q3 | $8.21M | Buy |
95,359
+27,102
| +40% | +$2.33M | ﹤0.01% | 2275 |
|
2022
Q2 | $5.65M | Buy |
68,257
+42,337
| +163% | +$3.5M | ﹤0.01% | 2563 |
|
2022
Q1 | $4.31M | Buy |
25,920
+17,300
| +201% | +$2.87M | ﹤0.01% | 2914 |
|
2021
Q4 | $1.44M | Sell |
8,620
-18,754
| -69% | -$3.14M | ﹤0.01% | 3743 |
|
2021
Q3 | $2.37M | Buy |
27,374
+15,718
| +135% | +$1.36M | ﹤0.01% | 3346 |
|
2021
Q2 | $633K | Buy |
11,656
+1,521
| +15% | +$82.6K | ﹤0.01% | 4306 |
|
2021
Q1 | $604K | Buy |
10,135
+1,270
| +14% | +$75.7K | ﹤0.01% | 4230 |
|
2020
Q4 | $462K | Buy |
8,865
+1,416
| +19% | +$73.8K | ﹤0.01% | 3864 |
|
2020
Q3 | $360K | Buy |
7,449
+2,047
| +38% | +$98.9K | ﹤0.01% | 3811 |
|
2020
Q2 | $280K | Buy |
5,402
+3,416
| +172% | +$177K | ﹤0.01% | 3858 |
|
2020
Q1 | $87K | Buy |
1,986
+149
| +8% | +$6.53K | ﹤0.01% | 4191 |
|
2019
Q4 | $74K | Sell |
1,837
-2,530
| -58% | -$102K | ﹤0.01% | 4169 |
|
2019
Q3 | $143K | Buy |
4,367
+2,910
| +200% | +$95.3K | ﹤0.01% | 3998 |
|
2019
Q2 | $112K | Buy |
+1,457
| New | +$112K | ﹤0.01% | 3980 |
|
2018
Q3 | – | Sell |
-2,500
| Closed | -$433K | – | 4188 |
|
2018
Q2 | $433K | Buy |
+2,500
| New | +$433K | ﹤0.01% | 3590 |
|